Menu Back toContinuing-Education

DIA/FDA Oligonucleotide-Based Therapeutics Conference

Convening industry and health authorities to inform, educate, and share advancements in oligonucleotide-based therapeutic product development.


As an IACET Authorized Provider, DIA offers CEUs for its programs that qualify under the ANSI/IACET Standard. DIA is authorized by IACET to offer the up to 1.8 CEUs. Participants must attend the entire conference or short course in order to be able to receive an IACET statement of credit. No partial credit will be awarded.

This event is approved by the Regulatory Affairs Professionals Society for 12 RAC credits.

To view DIA’s Grievance Policy, visit

NameCredit TypeMax CreditsCEU
DIA/FDA Oligonucleotide-Based Therapeutics ConfereCredit TypeIACETMax Credits18.00CEU1.800

Statement of Credit:

If you would like to receive a statement of credit, you must attend the conference, sign in at the DIA registration desk each day, and complete the online credit request process through My Transcript. Participants will be able to download a statement of credit upon successful submission of the credit request. My Transcript will be available for credit requests beginning Wednesday, November 1, 2017

To access My Transcript:
  • Visit, select “Sign in” and you will be prompted for your user ID and password
  • Choose MENU, found in the upper left corner
  • Under CONFERENCES select “Continuing Education"
  • Select the blue “My Transcript” button followed by “Credit Request” to process your credit request for the forum (and/or short courses, if applicable).

Contact us

Customer Service


On-Demand Complimentary Webinar

Oligonucleotide-Based Therapeutics in Rare Diseases

Insights Guide to Oligonucleotide-Based Therapeutics

Download Guide